menu ☰
menu ˟

[Correspondence] Questions regarding the CONCERN trial – Authors' reply

13 Jan 2018

We thank Ricky Turgeon for his Correspondence regarding our CONCERN trial1 on the gastrointestinal safety of celecoxib plus esomeprazole versus naproxen and esomeprazole in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding.

Click here to view the full article which appeared in The Lancet